Bio-Tech Int Institute

Research & Development, Pioneering Biosynthetic Innovation.

At Biotech International Institute (BII), we stand out with our unique approach to biosynthetic innovation. Our Research & Development department is the driving force behind this, exploring the frontier of biosynthetics. We merge biotechnology, chemistry, and engineering to design materials and molecules that outperform traditional systems while remaining sustainable and scalable.

What We Do

Our R&D team is dedicated to transforming concepts into practical, patent-pending solutions that have real-world applications. From molecular discovery to regulatory-ready development, we focus on biosynthetic pathways that support human health, agriculture, and planetary resilience. Current areas of focus include:

Pharmaceutical Biosynthetics – Developing therapeutic peptides, cannabinoid analogs, and neuroactive compounds with improved safety, efficacy, and delivery systems.

Agricultural Biosynthetics – Engineering microbial systems to produce repellents, growth enhancers, and eco-friendly protective formulations.

Material Biosynthetics – Creating regenerative composites and biofabricated infrastructure that merge biological function with industrial performance.

Why Biosynthetics Matter

Traditional production relies on extraction, petrochemicals, and unsustainable supply chains. Biosynthetics invert this paradigm by designing from biology itself:

Renewable inputs, not depleting resources

Precision-engineered molecules for targeted outcomes

Scalable production using microbial fermentation and synthetic biology

This approach not only reduces environmental impact but also opens doors to novel intellectual property and global health solutions.

From Bench to Impact

Our R&D channel is structured to take discoveries from the lab into commercially viable, patent-protected applications:

Discovery

Novel compound identification & pathway mapping

Engineering

Microbial/enzymatic optimization & CRISPR-based design

Validation

Preclinical assays, safety testing, and biosafety certification

Scale-Up

Fermentation, purification, and formulation at production scale

Commercialization

Partnership, licensing, and global deployment

Collaborations & Partnerships

Our work extends beyond borders. We actively collaborate with universities, Indigenous communities, and industry partners worldwide. Through these partnerships, we integrate academic research, cultural wisdom, and industrial expertise into our biosynthetic platforms, contributing to a global mission of sustainability and innovation. This global impact is what inspires us and what we invite you to be a part of.

If you’re interested in partnering with BII or exploring licensing opportunities, we invite you to contact us. By collaborating with us, you can gain access to our cutting-edge research, unique biosynthetic platforms, and a global network of partners. We believe that collaboration is key to our success, and we look forward to the opportunity to work together.

Redefining Brain & Biotech Health, Patent Pending Innovations

At Biotech International Institute, we develop next-generation neurotherapeutics and agricultural biotech solutions designed to restore balance, resilience, and longevity. Our platforms combine neuroscience, synthetic biology, and precision fermentation to create patent-pending systems that activate the body’s innate regenerative potential.

Neurological Innovations

NeuroReset™ | Neurophorol™ | Mycophorol™

Patent Pending – PATP1280.01 / 1280.04 © Biotech International Institute — Bill Carrington & Dominic Carrington 

NeuroReset™ – A revolutionary system for addiction recovery and post-dependency brain health, recalibrating neurotransmitter balance.

Neurophorol™ – A comprehensive and broad-spectrum neuroprotective molecule supporting cognition, neuroinflammation defense, and oxidative stress reduction.

Mycophorol™ – A fungal-derived therapeutic with advanced multi-pathway modulation for neurodegenerative disease and cognitive longevity.

Precision Peptide Therapeutics

NeuroRelief-P™ | NeuroRegen-P™ | NeuroReset-P™

Patent Pending – PATP1280.03 © Biotech International Institute

Bill Carrington & Dominic Carrington 

NeuroRelief-P™ – Peptide innovation for pain modulation, engineered to relieve chronic and neuropathic pain without systemic risks.

NeuroRegen-P™ – Activates regenerative signaling to drive axonal growth and synaptic repair for injury and degenerative conditions.

NeuroReset-P™ – Stabilizes neural circuits and supports recovery from substance dependency through structural and biochemical rebalancing.

AgriShield-X™ Next-Generation Livestock Protection

Patent Pending – PATP1280.02 © Biotech International Institute — Bill Carrington & Dominic Carrington 

AgriShield-X™ is our organic, biotech-driven livestock defense against parasitic threats such as screwworm. The system integrates:

Carvacrol – Plant-based antimicrobial & insecticidal agent

Limonene Oxide – Citrus-derived repellent enhancer

Chitosan Nanogels – Biodegradable encapsulation for sustained release

Releaf™ Topical Therapeutics Botanical Relief for Skin & Recovery

© Biotech International Institute — Darrell Fay

Releaf™ Burn Cream – Cannabinoid-rich salve for burns and irritation, providing fast-acting comfort and antimicrobial protection.

Releaf™ Burn & Pain Cream – Expanded formulation addressing localized pain, inflammation, and chronic skin stress.